TMDX
USDTransMedics Group Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$120.310
Kõrge
$125.220
Madal
$119.000
Maht
1.03M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
4.1B
Tööstusharu
Meditsiiniseadmed
Riik
United States
Kauplemisstatistika
Keskmine maht
1.00M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $147
Canaccord Genuity analyst William Plovanic maintains TransMedics Group with a Buy and raises the price target from $142 to $147.
Piper Sandler Maintains Overweight on TransMedics Group, Lowers Price Target to $140
Piper Sandler analyst Matt O'Brien maintains TransMedics Group with a Overweight and lowers the price target from $145 to $140.
Needham Upgrades TransMedics Group to Buy, Announces $148 Price Target
Needham analyst Mike Matson upgrades TransMedics Group from Hold to Buy and announces $148 price target.
Canaccord Genuity Maintains Buy on TransMedics Group, Maintains $142 Price Target
Canaccord Genuity analyst William Plovanic maintains TransMedics Group with a Buy and maintains $142 price target.
Jefferies Initiates Coverage On TransMedics Group with Buy Rating, Announces Price Target of $145
Jefferies analyst Young Li initiates coverage on TransMedics Group with a Buy rating and announces Price Target of $145.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.